win 64338 has been researched along with cyclic gmp in 2 studies
Studies (win 64338) | Trials (win 64338) | Recent Studies (post-2010) (win 64338) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
---|---|---|---|---|---|
19 | 0 | 2 | 22,346 | 333 | 4,062 |
Protein | Taxonomy | win 64338 (IC50) | cyclic gmp (IC50) |
---|---|---|---|
Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schölkens, BA; Wiemer, G; Wirth, KJ | 1 |
Dedio, J; Schölkens, BA; Wiemer, G; Wirth, K; Wohlfart, P | 1 |
2 other study(ies) available for win 64338 and cyclic gmp
Article | Year |
---|---|
The bradykinin B2 receptor antagonist WIN 64338 inhibits the effect of des-Arg9-bradykinin in endothelial cells.
Topics: Animals; Aorta; Binding, Competitive; Bradykinin; Bradykinin Receptor Antagonists; Cattle; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Naphthalenes; Nitric Oxide; Organophosphorus Compounds; Rabbits | 1994 |
Different B1 kinin receptor expression and pharmacology in endothelial cells of different origins and species.
Topics: Animals; Aorta; Bradykinin; Bradykinin Receptor Antagonists; Cattle; Cells, Cultured; Coronary Vessels; Cyclic GMP; DNA Primers; Endothelium, Vascular; Humans; Microcirculation; Naphthalenes; Organophosphorus Compounds; Polymerase Chain Reaction; Rats; Receptor, Bradykinin B1; Receptors, Bradykinin; Species Specificity; Transcription, Genetic; Umbilical Veins | 1997 |